Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
QVC INCQVC Reports 7.1% Revenue Decline Amid Chapter 11 Bankruptcy Filing
Instil Bio, Inc.Instil Bio Reports $4.2 Million Net Loss in Q1 2026, Significant Expense Reductions Noted
First Seacoast Bancorp, Inc.First Seacoast Bancorp Reports $508,000 Net Loss in Q1 2026, Enters Merger Agreement with Cambridge Financial Group
Securetech Innovations, Inc.SecureTech Innovations Reports $2.08M Revenue in Q1 2026, Net Loss of $401K
POWERCOMPUTE, INC.LM Funding America Reports Q1 2026 Revenue Decline to $2.1 Million
Pioneer Acquisition I CorpPioneer Acquisition I Corp Reports Net Income of $1.99M in Q1 2026
Zapata Quantum, Inc.Zapata Quantum Reports $1.31 Million Net Loss and $1.2 Million Operating Expenses for Q1 2026
Cocrystal Pharma, Inc.Cocrystal Pharma Reports Q1 2026 Financial Results with $2.3M Net Loss
NEXPOINT DIVERSIFIED REAL ESTATE TRUSTNexPoint Diversified Real Estate Trust Reports $21.3 Million Net Loss for Q1 2026
Pulmatrix, Inc.Pulmatrix Reports Q1 2026 Financial Results, Faces Operational Challenges Amid Merger with Eos
AirJoule Technologies Corp.AirJoule Technologies Reports $49.8 Million Net Loss and Strategic Partnerships for Growth
Venu Holding CorpVenu Holding Corporation Reports 11% Revenue Growth to $3.9 Million, Despite Net Loss
Indaptus Therapeutics, Inc.Indaptus Therapeutics Reports $2.5 Million Net Loss in Q1 2026, Seeks Additional Capital
HARTE HANKS INCHarte Hanks Reports $37.3 Million Revenue in Q1 2026, Down 10.3% Year-Over-Year
60 DEGREES PHARMACEUTICALS, INC.60 Degrees Pharmaceuticals Reports Q1 2026 Financial Results with Increased Net Loss
Enveric Biosciences, Inc.Enveric Biosciences Reports $1.6 Million Net Loss in Q1 2026, Focuses on R&D Funding
BioCardia, Inc.BioCardia Reports $2.3 Million Net Loss in Q1 2026, Plans to Raise Additional Capital
GT Biopharma, Inc.GT Biopharma Reports $2.8 Million Net Loss in Q1 2026, Zero Revenue
VerifyMe, Inc.VerifyMe Reports 60% Revenue Decline in Q1 2026 Amid Merger Plans
CREATIVE REALITIES, INC.Creative Realities Reports 68% Revenue Growth to $16.3 Million, Faces $7.5 Million Net Loss
Nuvera Communications, Inc.Nuvera Communications Reports $18.4 Million Revenue in Q1 2026, Driven by Data Services Growth
AVAX ONE TECHNOLOGY LTD.AVAX One Technology Reports $2.5M Revenue Growth and $46.4M Net Loss in Latest 10-Q
TANCHENG GROUP CO., LTD.Tancheng Group Reports No Revenue and Increased Net Loss in Latest Quarterly Filing
Rein Therapeutics, Inc.Rein Therapeutics Reports $5.8 Million Net Loss in Q1 2026, Focuses on LTI-03 Development
Local Bounti Corporation/DELocal Bounti Reports $13.3 Million Revenue in Q1 2026, Narrowing Net Loss to $12.7 Million